Abstracts

LOPINAVIR (AN HIV PROTEASE INHIBITOR) IMPAIRS UTERINE REMODELING DURING PREGNANCY

Exposure to protease inhibitor (PI) based combination antiretroviral therapy (cART) during pregnancy; especially Lopinavir (LPV) based cART during periconception, increases the prevalence of preterm delivery and low birth weight. PIs may contribute to these adverse events by lowering progesterone (P4) levels. P4 plays a central role in uterine preparation for pregnancy, and a critical P4-dependent…

POORER CONTROL OF VIRAL LOAD IN PATIENTS INFECTED PERINATALLY VERSUS DURING ADULTHOOD

Combined antiretroviral treatment (cART) allows most HIV-infected infants to reach adulthood. We studied whether the current virological response of perinatally-infected children and young adults to cART was similar to that of patients infected during adulthood, with a similar duration of infection and treatment history. Data from 5 ongoing French national ANRS cohorts were pooled: 1)…

UTILITY OF HCV CORE ANTIGEN FOR THE DIAGNOSIS OF ACUTE HCV IN HIGH-RISK INDIVIDUALS

To achieve micro-elimination of HCV in high-risk groups, early detection of acute HCV is important in order to link individuals into care/treatment and harm-reduction programmes. Current guidelines suggest regular anti-HCV screening with additional HCV-RNA for high-risk individuals with unexplained elevated serum aminotransferases. HCV core antigen (HCV-cAg) offers an alternative to HCV-RNA testing to confirm HCV…

DIVERSE OBSTETRICIAN HCV-SCREENING PRACTICES IN A LARGE REGIONAL HEALTH CARE SYSTEM

Given the onslaught of the opioid epidemic, the incidence of HIV and Hepatitis C (HCV) infection is increasing in reproductive age women. Unlike recommendations for universal HIV screening, HCV testing in pregnancy has been risk-based. Recent AASLD/IDSA guidelines recommend universal HCV screening. We hypothesized that prior to revised screening recommendations there was diversity in HCV…